| P2093 | author name string | Kemal Sarica | |
| | Sakip Erturhan | |
| | Bulent Altay | |
| P2860 | cites work | Disparate effects of calcium antagonists on renal microcirculation | Q71586300 |
| | Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients | Q72641845 |
| | [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers] | Q72809401 |
| | Effect of calcium antagonists on sympathetic activity | Q74747780 |
| | A prospective study of recurrence rate and risk factors for recurrence after a first renal stone | Q77914252 |
| | Limitation of shockwave-induced enhanced crystal deposition in traumatized tissue by verapamil in rabbit model | Q78124499 |
| | Prevention of nephrolithiasis | Q32064126 |
| | Metabolic evaluation and therapy | Q34125019 |
| | Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study | Q34732675 |
| | Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine | Q35544820 |
| | Calcium antagonists and renal protection. Current status and future perspectives | Q35671299 |
| | Segmentally distinct effects of depolarization on intracellular [Ca2+] in renal arterioles | Q36755558 |
| | Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells | Q40520493 |
| | Current status of calcium channel blockers | Q40579261 |
| | Nifedipine, verapamil and diltiazem block shock-wave-induced rises in cytosolic calcium in MDCK cells. | Q40963792 |
| | Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney | Q43744708 |
| | Oral potassium citrate treatment for idiopathic hypocitruria in children with calcium urolithiasis | Q44222815 |
| | Prospective Study on the Efficacy of a Selective Treatment and Risk Factors for Relapse in Recurrent Calcium Oxalate Stone Patients | Q44590161 |
| | The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy | Q46931633 |
| | Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children. | Q51774652 |
| | Are calcium antagonists potential antilithiasic drugs? | Q69467257 |
| | Effect of nifedipine on urinary calcium and oxalate excretion in renal stone formers | Q69554410 |
| | Analytical reviews in clinical biochemistry: calcium measurement | Q69635052 |
| | [Comparative quantitative clinico-chemical analysis of the characteristics of 24-hour urine and morning urine] | Q69727776 |
| | [Effect of calcium antagonists (nifedipine) on nephrocalcinosis and calcium excretion in the rat] | Q70066430 |
| P433 | issue | 1 | |
| P921 | main subject | verapamil | Q410291 |
| P304 | page(s) | 23-27 | |
| P577 | publication date | 2006-12-13 | |
| P1433 | published in | Urological Research | Q15746542 |
| P1476 | title | Effect of verapamil on urinary stone-forming risk factors | |
| P478 | volume | 35 | |